← SynDRA
DARIFENACIN
SynDRA canonical compound SYN0005484 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CHRM5 |
|---|
| Mechanism of action | Acetylcholine receptor antagonist |
|---|
| Indication | urinary incontinence |
|---|
| Disease area | urology |
|---|
All known targets
- CHRM3
- CHRM2
- CHRM1
- CHRM4
- CHRM5
- ADRB1
- ADRB2
- Chrm2
- Chrm3
- DRD2
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRM3 ANTAGONIST
- Muscarinic acetylcholine receptor M3 antagonist
- CHRM2 ANTAGONIST
- Muscarinic acetylcholine receptor M2 antagonist
Drug classes
- Cholinergic Muscarinic Antagonists
- Cholinergic Agents
- Cholinergic Antagonists
- Muscarinic Antagonists
- Neurotransmitter Agents
- Urological Agents
- Cholinergic Muscarinic Antagonist
ATC classes
Cross-references
Synonyms
- enablex
- darifenacin hydrobromide
- emselex
- Darifenacine
- Darifenacina
- Darifenacin extended release
- UK-88525
- UK88525
- Enablex
- Emselex
- UNII-APG9819VLM
- APG9819VLM
- CHEMBL1346
- CHEBI:391960
- (S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide
- 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
- darifenacine
- [3H]darifenacin
- 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide
- NCGC00168775-01
- Darifenacin (USAN/INN)
- Darifenacinum
- Darifenacin [USAN:INN:BAN]
- Emselex (TN)
- Enablex (TN)
- 2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
- 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide
- Darifenacin [USAN]
- DARIFENACIN [MI]
- DARIFENACIN [INN]
- DARIFENACIN [VANDF]
- DARIFENACIN [MART.]
- SCHEMBL56574
- DARIFENACIN [WHO-DD]
- GTPL319
- GTPL321
- MLS003876823
- DTXSID2048290
Look up DARIFENACIN in the interactive SynDRA portal →